15 June 2016 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
1 February 2017 in Anesthesia & Analgesia
Automated systems can improve the stability of controlled variables and reduce the workload in clinical practice without increasing the risks to patients. We conducted this review and meta-analysis to assess the clinical performance of closed-loop systems compared with manual control. Our primary outcome was the accuracy of closed-loop systems in comparison with manual control to maintain a given variable in a desired target range. The occurrence of overshoot and undershoot episodes was the secondary outcome. We retrieved randomized controlled trials on accuracy and safety of closed-loop systems versus manual control. Our primary outcome was the percentage of time during which the system was able to maintain a given variable (eg, bispectral index or oxygen saturation) in a desired range or the proportion of the target measurements that was within the required range. Our secondary outcome was the percentage of time or the number of episodes that the controlled variable was above or below the target range. The standardized mean difference and 95% confidence interval (CI) were calculated for continuous outcomes, whereas the odds ratio and 95% CI were estimated for dichotomous outcomes. Thirty-six trials were included. Compared with manual control, automated systems allowed better maintenance of the controlled variable in the anesthesia drug delivery setting (95% CI, 11.7%–23.1%; percentage of time,P< 0.0001, number of studies:n= 15), in patients with diabetes mellitus (95% CI, 11.5%–30.9%; percentage of time,P= 0.001,n= 8), and in patients mechanically ventilated (95% CI, 1.5%–23.1%; percentage of time,P= 0.03,n= 8). Heterogeneity among the studies was high (>75%). We observed a significant reduction of episodes of overshooting and undershooting when closed-loop systems were used. The use of automated systems can result in better control of a given target within a selected range. There was a decrease of overshooting or undershooting of a given target with closed-loop systems.
1 December 2009 in British Journal of Anaesthesia
Regional cerebral oxygen saturation (SctO2) has recently been shown to decrease significantly during thoracic surgery. The present study investigates whether these desaturations are related to postoperative complications. Fifty patients undergoing thoracic surgery with a single-lung ventilation (SLV) of >45 min duration were enrolled. Regional cerebral oxygen saturation was measured using absolute oximetry; standard clinical variables, and SOFA and Clavien scores were recorded. Correlation between minimum SctO2 during SLV and postoperative complication scores was analysed using Pearson's correlation test, χ2 test, and logistic regression. Forty-seven patients underwent lobectomy, two patients a pneumonectomy and 1 patient a chest wall resection. Eighty-two per cent of the patients had a decrease in SctO2 of >15% from baseline value, and 10% of the patients had a minimal absolute SctO2 value between 45% and 55%. The minimal absolute SctO2 values during SLV correlated with the Clavien score (R2=0.098, P=0.0201) and the non-respiratory SOFA score (R2=0.090, P=0.0287). By defining a threshold of SctO2=65%, the odds ratio of having a non-respiratory organ failure was 2.37 (95% CI 1.18–4.39, P=0.043) and a complication according to the Clavien score (Clavien score >0) was 3.19 (95% CI 1.60–6.34, P=0.0272). Thoracic surgery with SLV seemed to be associated with a significant decrease in SctO2, and minimal SctO2 values correlated positively with postoperative complications.
3 October 2008 in British Journal of Anaesthesia
Single-lung ventilation (SLV) during thoracic surgery causes important cardiopulmonary disturbances. Absolute cerebral oximetry was used to determine the incidence and magnitude of the decrease in cerebral oxygen saturation (Sct o2) in patients undergoing SLV during thoracic surgery. Data were obtained from 20 consecutive patients undergoing thoracic surgery and necessitating SLV of more than 1 h. The FORESIGHT™ (CASMED, USA) absolute oximeter was used to measure left, right, and average absolute Sct o2 every 5 min from the awake state to extubation. Bispectral index and standard monitoring parameters were also recorded every 5 min. Blood gas analysis was performed every 15 min. Data median (IQR) (range) were analysed using repeated-measures anova and Spearman’s correlation test, P<0.05. Patients [median age 65 yr (range 46–75)] showed an absolute Sct o2 of 80% (78, 82) (74–87) in the awake state, which decreased to a minimum Sct o2 value of 63% (57, 65) (53–73) during SLV to recover to an Sct o2 of 71% immediately after extubation. During SLV, all patients had a decrease of more than 15% of the initial Sct o2 and 70% of patients had a decrease of more than 20%. The decrease in Sct o2 was not correlated with any standard clinical parameters, for example, arterial pressure, blood loss, peripheral oxygen saturation, or Pa o2. Thoracic surgery with SLV seems to be associated with a significant decrease of Sct o2 in the majority of patients. Parameters such as peripheral oxygen saturation or Po2 which are used to guide SLV during thoracic surgery are not sufficient to detect significant cerebral oxygen desaturations.
1 February 2017 in Plastic and Reconstructive Surgery
Summary: Alongside the ongoing evolution of surgical training toward a competency-based paradigm has come the need to reevaluate the role of surgical simulation in residency. Simulators offer the ability for trainees to acquire specific skills and for educators to objectively assess the progressive development of these skills. In this article, the authors discuss the historical evolution of surgical simulation, with a particular focus on its past and present role in plastic surgery education. The authors also discuss the future steps required to further advance plastic surgery simulation in an effort to continue to train highly competent plastic surgery graduates.
13 April 2020 in Plastic and Reconstructive Surgery
STStephanie Md Thibaudeau
Background: Nonsurgical management of de Quervain disease relies mainly on the use of oral nonsteroidal antiinflammatory drug administration, splint therapy, and corticosteroid injections. Although the latter is most effective, with documented success rates of 61 to 83 percent, there exists no clear consensus pertaining to conservative treatment protocols conferring the best outcomes. This article reports on all present conservative treatment modalities in use for the management of de Quervain disease and highlights specific treatment- and patient-related factors associated with the best outcomes. Methods: A systematic search was performed using the PubMed database using appropriate search terms; two independent reviewers evaluated retrieved articles using strict inclusion and exclusion criteria. Results: A total of 66 articles met the inclusion criteria for review, consisting of 22 articles reporting on outcomes following a single conservative treatment modality, eight articles reporting on combined treatment approaches, 13 articles directly comparing different conservative treatment regimens, and 23 case reports. Conclusions: A multimodal approach using splint therapy and corticosteroid injections appears to be more beneficial than either used in isolation. Although there exists some evidence showing that multipoint injection techniques and multiple injections before surgical referral may provide benefit over a single point injection technique and a single injection before surgery, corticosteroid use is not benign and should thus be performed with caution. Ultrasound was proven valuable in the visualization of an intercompartmental septum, and ultrasound-guided injections were shown to both be more accurate and confer better outcomes. Several prior and concurrent medical conditions may affect conservative treatment outcome. A Level I to II evidence-based treatment protocol is recommended for the optimal nonsurgical management of de Quervain disease.